TrimRx vs MEDVi 2026
Two of the highest-traffic compounded GLP-1 telehealth brands compared head-to-head. Both start at $179/mo — but the data tells a clear story on which one is better verified and more transparent.
At a Glance
MEDVi
Editor’s PickBest for patients who want a verified mid-tier provider with transparent pricing for both semaglutide and tirzepatide. Highest brand-search volume in our verified stack.
- Semaglutide $179–$249/mo (Gronk-verified)
- Tirzepatide $229–$299/mo (Gronk-verified)
- 33,000 monthly brand searches — largest patient base signal
- Cancel anytime
- Physician-supervised program
TrimRx
Pending VerificationEntry-level pricing starts at $179/mo. Strong organic search traffic suggests real patient volume, but the full product catalog requires manual verification.
- From $179/mo entry (site-crawled May 2026)
- 2,700+ monthly brand searches
- Physician-supervised program
- Full dose/plan catalog requires manual verification
- Tirzepatide availability/pricing unconfirmed
Full Side-by-Side
MEDVi data is Gronk-verified (May 2026). TrimRx data is sourced from site crawl where possible; unverifiable fields are marked VERIFY.
| Dimension | MEDVi | TrimRx |
|---|---|---|
| Compounded Semaglutide — entry price | $179–$249/mo (Gronk-verified May 2026) | From $179/mo (catalog VERIFY) |
| Compounded Tirzepatide | $229–$299/mo (Gronk-verified May 2026) | VERIFY (SPA-blocked catalog) |
| Pricing transparency | Range published; full tier table requires live login | SPA-rendered site limits public catalog access |
| Dose-escalation upcharge | VERIFY (range-based pricing implies tiered) | VERIFY |
| Cancellation policy | Anytime | VERIFY |
| Includes physician consult | Yes | Yes |
| Labs included | Not included (standard for this tier) | VERIFY |
| Brand search volume (Ahrefs) | ~33,000/mo on "medvi" — highest in our stack | ~2,700/mo on "trimrx" |
| Active affiliate program | Pending (Katalys) | Pending (Everflow direct) |
| Category / positioning | Reliable mid-tier compounded GLP-1 | Weight-loss program with GLP-1 medication |
| Editorial badge | Editor's Pick (GLP1CompareHub) | None currently assigned |
Pricing Deep Dive
MEDVi — Verified Range
MEDVi pricing is Gronk-verified as of May 2026. They publish a price range; exact per-dose tier structure requires live account access.
- Range: $179–$249/mo
- All doses included in plan (no upcharge — VERIFY)
- Physician consult included
- Range: $229–$299/mo
- Full dose escalation schedule: VERIFY
- Cancel anytime confirmed
TrimRx — Entry Data Only
TrimRx's website is a JS-rendered SPA. Our crawler confirmed the entry-tier headline but cannot extract the full dose or plan catalog without a live authenticated session.
- Entry price: from $179/mo (site meta, May 2026)
- Physician consult: included
- Tirzepatide availability: unconfirmed
- Plan structure / tiers: VERIFY
- Dose-escalation upcharges: VERIFY
Looking for lower prices? Consider these alternatives.
Both TrimRx and MEDVi sit in the $179–$299/mo mid-tier. If price is your primary driver, several providers in our verified stack offer lower entry points:
- Strut Health — $99/mo compounded semaglutide (Gronk-verified)
- GobyMeds — $99/mo entry (public affiliate program)
- TMates — $158/mo on 12-month plan (verified, #1 EPC in our Katalys stack)
Brand Search Volume: What It Tells You
When patients search directly for a provider by name, it signals real-world patient volume — not just marketing spend. High brand search = more people have heard of it, used it, or been referred to it.
MEDVi — 33K Monthly Brand Searches
MEDVi has the highest organic brand-search volume of any provider in our verified GLP-1 stack — approximately 33,000 monthly searches on “medvi” and 27,000+ on “medvi reviews” (Ahrefs May 2026). This is a meaningful trust proxy.
Implication: A large existing patient base suggests operational scale, a working prescription workflow, and enough satisfied patients to drive word-of-mouth. For prospective patients, it lowers the perceived risk of joining.
TrimRx — 2,700 Monthly Brand Searches
TrimRx shows 2,700 monthly searches on “trimrx” and 3,000 on “trimrx reviews” (Ahrefs May 2026). Meaningful but substantially smaller than MEDVi. The “reviews” search volume ratio (3,000 vs 2,700 brand) suggests patients actively seek social proof before committing.
Implication: Smaller brand footprint doesn’t mean worse service — it may mean a newer or more narrowly-marketed provider. But it does mean less independent verification of patient outcomes is available online.
Who Should Pick Which?
Pick MEDVi if:
- You want a verified pricing range before starting the intake process — MEDVi publishes $179–$249 sema and $229–$299 tirz publicly.
- You want compounded tirzepatide — MEDVi pricing is confirmed; TrimRx availability is not.
- You value a larger, more established patient community as a trust signal.
- You want “cancel anytime” confirmed explicitly — MEDVi states this publicly.
Consider TrimRx if:
- You’ve seen positive reviews for TrimRx specifically from your network or community — word-of-mouth from known patients is strong signal.
- You’re willing to go through the intake quiz to get fully personalized pricing, and you find MEDVi’s online UX less convenient.
- TrimRx’s catalog turns out to be competitively priced once you complete their intake — our current data gap leaves this open.
Our Verdict
MEDVi is our editorial pick for this comparison. With Gronk-verified pricing for both semaglutide ($179–$249/mo) and tirzepatide ($229–$299/mo), a published cancel-anytime policy, and the highest brand-search volume in our verified stack (33K monthly), MEDVi wins on data transparency and trust signal.
TrimRx is a legitimate provider with real patient volume — the 2,700 monthly brand searches and high review search ratio confirm this. But its SPA-based site prevents us from verifying the full pricing catalog, tirzepatide availability, or dose-escalation policies. Until we can manually verify, we cannot make a confident recommendation on TrimRx pricing tiers.
For patients comparing these two specifically: Start with MEDVi if you want confirmed pricing upfront. If you’re curious about TrimRx, go through their intake quiz — the price you’re quoted after the medical profile may be competitive with or below the MEDVi range, depending on your dose needs.
FAQ
Which is cheaper, TrimRx or MEDVi?
Both start at approximately $179/mo for compounded semaglutide. MEDVi pricing is Gronk-verified at $179–$249/mo for semaglutide and $229–$299/mo for tirzepatide. TrimRx lists "from $179/mo" on its site (crawled May 2026) but its full catalog is rendered via JavaScript and requires manual verification — confirmed pricing tiers beyond the entry point are not yet available. For fully verified pricing tiers, MEDVi currently has more transparent published data.
Do both TrimRx and MEDVi offer compounded tirzepatide?
MEDVi offers compounded tirzepatide at $229–$299/mo (Gronk-verified May 2026). TrimRx's tirzepatide offering and pricing require manual verification — its SPA-based site prevents automated catalog extraction. If tirzepatide is your medication of interest, MEDVi is the better-verified option between these two.
Which has more brand recognition, TrimRx or MEDVi?
MEDVi has significantly higher organic brand-search volume — approximately 33,000 monthly searches on "medvi" and 27,000+ on "medvi reviews" per Ahrefs data. TrimRx shows 2,700 monthly searches on "trimrx" and 3,000 on "trimrx reviews." Higher brand-search volume generally indicates a larger existing patient base and stronger word-of-mouth, both trust signals for prospective patients.
Is TrimRx or MEDVi a legitimate telehealth provider?
Both are legitimate telehealth weight-loss programs offering compounded GLP-1 medications through licensed providers. Compounded semaglutide and tirzepatide are legal to prescribe under 503A compounding pharmacy rules during shortage periods, though the FDA has increased enforcement scrutiny in 2025–2026. As with all GLP-1 telehealth programs, patients should verify current compliance status and consult a physician before starting any weight-loss medication.
How do TrimRx and MEDVi compare to lower-cost alternatives like GobyMeds?
GobyMeds offers compounded semaglutide starting at $99/mo — substantially below either TrimRx ($179+) or MEDVi ($179–$249). If lowest price is the primary decision factor and you qualify, GobyMeds or Strut Health ($99/mo) represent better entry points. TrimRx and MEDVi sit in the mid-tier of our verified stack and compete more on brand trust and program depth than raw price.
Which provider should I pick between TrimRx and MEDVi?
MEDVi is our editorial pick for this comparison. It offers Gronk-verified pricing tiers for both semaglutide and tirzepatide, has substantially higher brand-search volume (a proxy for patient base and trust), and carries an "Editor's Pick" designation in our provider database. TrimRx may be worth considering if its full catalog — once manually verified — reveals competitive pricing tiers, but the current data gap makes MEDVi the more transparent choice.
How this page is reviewed
Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).
Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.